146 related articles for article (PubMed ID: 2754456)
1. A phase II study of cisplatin therapy in recurrent childhood brain tumors. A report from the Childrens Cancer Study Group.
Bertolone SJ; Baum ES; Krivit W; Hammond GD
J Neurooncol; 1989 May; 7(1):5-11. PubMed ID: 2754456
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin in recurrent pediatric brain tumors. A POG Phase II study. A Pediatric Oncology Group Study.
Sexauer CL; Khan A; Burger PC; Krischer JP; van Eys J; Vats T; Ragab AH
Cancer; 1985 Oct; 56(7):1497-501. PubMed ID: 4040799
[TBL] [Abstract][Full Text] [Related]
3. PCNU in the treatment of recurrent medulloblastoma and ependymoma--a POG Study.
Ragab AH; Burger P; Badnitsky S; Krischer J; Van Eys J
J Neurooncol; 1986; 3(4):341-2. PubMed ID: 3958779
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin in the treatment of recurrent childhood primary brain tumors.
Walker RW; Allen JC
J Clin Oncol; 1988 Jan; 6(1):62-6. PubMed ID: 2826716
[TBL] [Abstract][Full Text] [Related]
5. Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group.
Nicholson HS; Kretschmar CS; Krailo M; Bernstein M; Kadota R; Fort D; Friedman H; Harris MB; Tedeschi-Blok N; Mazewski C; Sato J; Reaman GH
Cancer; 2007 Oct; 110(7):1542-50. PubMed ID: 17705175
[TBL] [Abstract][Full Text] [Related]
6. Carboplatin in childhood brain tumors. A Children's Cancer Study Group Phase II trial.
Gaynon PS; Ettinger LJ; Baum ES; Siegel SE; Krailo MD; Hammond GD
Cancer; 1990 Dec; 66(12):2465-9. PubMed ID: 2249186
[TBL] [Abstract][Full Text] [Related]
7. Phase II evaluation of dibromodulcitol in the treatment of recurrent medulloblastoma, ependymoma, and malignant astrocytoma.
Levin VA; Edwards MS; Gutin PH; Vestnys P; Fulton D; Seager M; Wilson CB
J Neurosurg; 1984 Dec; 61(6):1063-8. PubMed ID: 6502234
[TBL] [Abstract][Full Text] [Related]
8. Results of treatment of children with recurrent medulloblastoma/primitive neuroectodermal tumors with lomustine, cisplatin, and vincristine.
Lefkowitz IB; Packer RJ; Siegel KR; Sutton LN; Schut L; Evans AE
Cancer; 1990 Feb; 65(3):412-7. PubMed ID: 2153428
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: the Duke experience.
Turner CD; Gururangan S; Eastwood J; Bottom K; Watral M; Beason R; McLendon RE; Friedman AH; Tourt-Uhlig S; Miller LL; Friedman HS
Neuro Oncol; 2002 Apr; 4(2):102-8. PubMed ID: 11916501
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin, ara-C and etoposide (PAE) in the treatment of recurrent childhood brain tumors.
Corden BJ; Strauss LC; Killmond T; Carson BS; Wharam MD; Kumar AJ; Piantadosi S; Robb PA; Phillips PC
J Neurooncol; 1991 Aug; 11(1):57-63. PubMed ID: 1919647
[TBL] [Abstract][Full Text] [Related]
11. A phase II evaluation of thiotepa in pediatric central nervous system malignancies.
Heideman RL; Packer RJ; Reaman GH; Allen JC; Lange B; Horowitz ME; Steinberg SM; Gillespie A; Kovnar EH; Balis FM
Cancer; 1993 Jul; 72(1):271-5. PubMed ID: 8508417
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy of recurrent pediatric posterior fossa tumors.
Edwards MS; Levin VA; Wilson CB
Clin Neurosurg; 1983; 30():209-25. PubMed ID: 6667576
[No Abstract] [Full Text] [Related]
13. [Chemotherapy of malignant brain tumors in childhood].
Knerich R; Butti G; Pezzotta S; Robustelli della Cuna G; Adinolfi D; Pavesi L
Minerva Med; 1984 Jun; 75(24):1441-4. PubMed ID: 6738898
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin therapy in recurrent childhood brain tumors.
Khan AB; D'Souza BJ; Wharam MD; Champion LA; Sinks LF; Woo SY; McCullough DC; Leventhal BG
Cancer Treat Rep; 1982 Dec; 66(12):2013-20. PubMed ID: 6890409
[TBL] [Abstract][Full Text] [Related]
15. A high-dose busulfan-thiotepa combination followed by autologous bone marrow transplantation in childhood recurrent ependymoma. A phase-II study.
Grill J; Kalifa C; Doz F; Schoepfer C; Sainte-Rose C; Couanet D; Terrier-Lacombe MJ; Valteau-Couanet D; Hartmann O
Pediatr Neurosurg; 1996 Jul; 25(1):7-12. PubMed ID: 9055328
[TBL] [Abstract][Full Text] [Related]
16. Carboplatin and recurrent childhood brain tumors.
Allen JC; Walker R; Luks E; Jennings M; Barfoot S; Tan C
J Clin Oncol; 1987 Mar; 5(3):459-63. PubMed ID: 3546620
[TBL] [Abstract][Full Text] [Related]
17. Phase II treatment of medulloblastoma and pineoblastoma with melphalan: clinical therapy based on experimental models of human medulloblastoma.
Friedman HS; Schold SC; Mahaley MS; Colvin OM; Oakes WJ; Vick NA; Burger PC; Bigner SH; Borowitz M; Halperin EC
J Clin Oncol; 1989 Jul; 7(7):904-11. PubMed ID: 2738624
[TBL] [Abstract][Full Text] [Related]
18. Ventriculolumbar perfusion of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosou rea hydrochloride.
Kochi M; Kuratsu J; Mihara Y; Takaki S; Seto H; Uemura S; Ushio Y
Neurosurgery; 1993 Nov; 33(5):817-23. PubMed ID: 8264878
[TBL] [Abstract][Full Text] [Related]
19. Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumors: results of a Phase II study.
Prados MD; Edwards MS; Chang SM; Russo C; Davis R; Rabbitt J; Page M; Lamborn K; Wara WM
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):279-85. PubMed ID: 10030250
[TBL] [Abstract][Full Text] [Related]
20. A Phase II clinical trial of idarubicin administered to children with relapsed brain tumors.
Arndt CA; Krailo MD; Steinherz L; Scheithauer B; Liu-Mares W; Reaman GH
Cancer; 1998 Aug; 83(4):813-6. PubMed ID: 9708950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
